Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210033705 210013922 1.68 71.4 null 2015-06-30 2015-09-30 Carboplatin + Paclitaxel (weekly) N null 210034650 LIPOSOMAL CYTARABINE
210033706 210013924 1.77 50.35 Curative (C) 2018-07-16 2018-07-22 DOXORUBICIN N N 210034878 CYTARABINE
210033707 210013927 1.69 19.75 Curative (C) 2016-02-07 2016-05-10 Cyclophosphamide High Dose 02 N 210035018 UKALL2003
210033708 210013930 1.75 78 Disease modification (D) 2018-06-11 2018-06-11 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N N 210035201 CARBO + ETOPOSIDE + VINCRISTINE
210033709 210022694 1.62 61.8 Palliative (P) null 2019-09-16 CISPLATIN + ETOPOSIDE Y null 210035396 DAUNORUBICIN + VNCRISTINE
210033710 210033722 null 76.1 Curative (C) 2016-12-13 2017-08-07 PACLITAXEL N N 210035468 CLL210 TRIAL
210033711 210013939 1.77 10.7 Curative (C) 2016-12-26 2017-01-06 GEM-P 2 N 210035520 TRASTUZUMAB
210033712 210022697 1.75 60.6 Curative (C) 2016-01-23 2016-07-26 CNS LGG Irinotecan & Bevacizumab N N 210035533 DOCETAXEL
210033713 210013952 null 47.9 Curative (C) 2017-10-12 2017-11-11 Maintenance Therapy ALL null N 210036454 NILOTINIB
210033714 210013956 1.91 91.2 Curative (C) 2015-02-12 2015-02-16 IVAC 2 N 210036485 CLL210 TRIAL
210033715 210022706 1.73 79.2 Adjuvant (A) 2020-03-31 2020-03-31 Bortezomib + CYCLOPHOSPHAMIDE 2 N 210036496 MPT
210033716 210013961 1.71 94 Disease modification (D) 2019-10-25 2019-10-25 PACLITAXEL N N 210036578 CYCLOPHOSPHAMIDE HIGH DOSE
210033717 210013964 1.59 47 Curative (C) null 2015-11-16 Cytarabine Intrathecal (any age) 2 N 210036643 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
210033718 210022719 1.72 39.2 Curative (C) 2019-05-30 2019-06-07 CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE N N 210037672 CLL210 TRIAL
210033719 210013981 null 53.5 Disease modification (D) 2020-02-22 2020-03-21 Obinutuzumab N null 210037675 CYTARABINE INTRATHECAL
210033720 210013988 1.82 26.8 Adjuvant (A) 2018-02-24 2018-03-10 CLARITY Trial N N 210038079 MITOMYCIN INTRAVESICULAR
210033721 210013995 0 70.8 Curative (C) null 2018-09-08 Clofarabine + Cytarabine N N 210038641 IVE-R
210033722 210022733 1.65 null Curative (C) 2014-11-17 2015-01-28 DACTINOMYCIN + CYCLO + VINCRISTINE N Y 210039506 CODOX M
210033723 210037469 null 71.4 Disease modification (D) 2017-06-29 2017-09-13 IPILIMUMAB + NIVOLUMAB 02 null 210039555 ICE-R
210033724 210014010 1.76 63 Palliative (P) 2016-06-20 2016-10-12 Mitomycin Intravesical null N 210039663 UKALL2003
210033725 210014014 1.64 null Curative (C) 2017-09-29 2017-11-11 Alemtuzumab + Cyclophos TBI Allo N N 210040040 BEAM
210033726 210014025 1.7 null Curative (C) null 2018-03-27 CARBOPLATIN + VINORELBINE Y N 210040409 UKALL 60+ TRIAL
210033727 210022742 null 59.2 Disease modification (D) 2017-12-25 2017-12-25 CLL210 TRIAL N null 210041159 ABVD
210033728 210014041 1.86 69.9 Neo-adjuvant (N) 2017-03-25 2017-04-01 Irinotecan + Modified De Gramont N N 210041453 UKALL2003
210033729 210022748 null 92 Disease modification (D) 2018-09-13 2019-09-23 PNET 4 HIT-SIOP Maintenance null N 210041755 TAVAREC TRIAL
210033730 210028266 1.6 47 Disease modification (D) 2019-01-11 2019-01-16 Alemtuzumab + Cyclophos TBI Allo N N 210041781 CLL210 TRIAL
210033731 210031617 1.64 null Curative (C) 2016-10-11 2017-04-12 LENVATINIB N N 210042046 ALL MAINTENANCE
210033732 210014057 1.84 63.8 Disease modification (D) 2015-06-25 2016-03-29 CARBO + ETOPOSIDE + VINCRISTINE N Y 210042047 CISPLATIN + ETOPOSIDE
210033733 210022762 1.75 89 null 2015-10-02 2018-05-19 BR14 TRIAL N N 210024514 ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE
210033734 210014071 null 85.6 Disease modification (D) 2019-06-22 2019-09-21 Cytarabine intrathecal N N 210030920 CYCLOPHOSPHAMIDE HIGH DOSE
210033735 210028274 1.81 78.5 Curative (C) 2017-09-29 2017-10-06 Bortezomib + Cyclophos + Dex 02 N 210034307 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE
210033736 210014086 1.62 34 Palliative (P) 2017-12-28 2017-12-28 CYTARABINE + ETOPOSIDE 2 null 210039936 ALL MAINTENANCE
210033737 210022777 1.72 38 Palliative (P) null 2019-06-03 Panitumumab null N 210041640 CLL210 TRIAL
210033738 210014093 1.53 75.3 Palliative (P) 2020-01-30 2020-01-30 Ibrutinib + Rituximab N N 210013365 DAUNORUBICIN + VNCRISTINE
210033740 210032406 1.65 56.5 Palliative (P) 2016-04-10 2016-04-16 Temozolomide 200mg/m2 N N 210000163 TEMOZOLOMIDE
210033741 210004326 null 59 Adjuvant (A) 2014-10-08 2015-04-08 TEMOZOLOMIDE 2 N 210000208 TEMOZOLOMIDE
210033742 210004339 1.64 null Adjuvant (A) 2016-05-27 2016-06-03 Temozolomide 200mg/m2 N N 210000223 TEMOZOLOMIDE
210033743 210004346 1.78 55.6 Adjuvant (A) 2014-04-14 2014-06-04 TEMOZOLOMIDE 02 N 210000265 TEMOZOLOMIDE
210033744 210017255 1.55 92.4 Disease modification (D) 2018-03-09 2018-03-31 Temozolomide 150mg/m2 02 N 210000286 TEMOZOLOMIDE
210033745 210024691 1.81 0 Adjuvant (A) 2017-06-05 2018-03-13 Temozolomide 200mg/m2 N N 210000362 TEMOZOLOMIDE
210033746 210032416 1.72 77.5 Palliative (P) 2015-10-23 2015-10-25 Temozolomide 200mg/m2 N N 210000395 TEMOZOLOMIDE
210033747 210032417 null 69.4 Adjuvant (A) 2017-07-07 2017-07-07 TEMOZOLOMIDE 2 N 210000398 TEMOZOLOMIDE
210033748 210032421 1.74 null Palliative (P) 2017-04-06 2017-07-18 TEMOZOLOMIDE 02 N 210000497 TEMOZOLOMIDE
210033749 210004400 1.75 98 Adjuvant (A) 2013-11-28 2014-04-15 TEMOZOLOMIDE 02 null 210000561 TEMOZOLOMIDE
210033750 210004403 1.67 80.1 Adjuvant (A) 2017-12-27 2018-05-03 Temozolomide 200mg/m2 2 N 210000562 TEMOZOLOMIDE
210033751 210004406 1.78 96 Adjuvant (A) 2016-10-19 2016-10-21 Temozolomide 200mg/m2 N N 210000602 TEMOZOLOMIDE
210033752 210038311 1.89 133 Curative (C) 2016-11-19 2017-02-18 TEMOZOLOMIDE 02 N 210000612 TEMOZOLOMIDE
210033753 210004408 1.75 null Palliative (P) 2013-11-21 2016-02-12 TEMOZOLOMIDE 2 N 210000663 TEMOZOLOMIDE
210033754 210004412 1.69 null Adjuvant (A) 2018-03-11 2018-03-11 Temozolomide 200mg/m2 02 N 210000691 TEMOZOLOMIDE
210033755 210024722 1.65 96 Palliative (P) null 2017-02-04 Temozolomide 200mg/m2 N N 210000818 TEMOZOLOMIDE